HELP     Sign In
Search

Relevance to Autism

El Chehadeh et al., 2022 reported eight individuals from seven unrelated families presenting a neurodevelopmental disorder characterized by developmental delay, intellectual disability, and behavioral/neuropsychiatric manifestations (including ASD in 4/8 individudals) and harboring rare potential disease-causing variants in SLITRK2; functional studies subsequently showed that some of these variants caused impaired surface trafficking in transfected HEK293T cells and impaired dendritic targeting in cultured hippocampal neurons, as well as an inability to rescue deficits in excitatory synapse development and transmission in Slitrk2-cKO hippocampal neurons. El Chehadeh et al., 2022 also demonstrated that Slitrk2 conditional knockout mice were found to exhibit impaired long-term memory and abnormal gait. Slitrk2 knockout mice had previously been shown to exhibit increased locomotor activity in novel environments, antidepressant-like behaviors, enhanced vestibular function, and increased plasticity at mossy fiber-CA3 synapses with reduced sensitivity to serotonin (Katayama et al., 2022). The protein encoded by the SLITRK2 gene has been shown to interact with the protein products of the ASD-associated genes SHANK3, DLG2, and DLG4, and these interactions are required for SLITRK2-mediated excitatory synapse development (Han et al., 2019; Loomis et al., 2020). A maternally-inherited SLITRK2 missense variant (p.Val89Met) that was originally identified as being transmitted to three sisters with schizophrenia in Piton et al., 2011 was experimentally shown in Kang et al., 2016 to compromise synapse formation activity in cultured hippocampal neurons.

Molecular Function

This gene encodes an integral membrane protein that contains two N-terminal leucine-rich repeats domains and contains C-terminal regions similar to neurotrophin receptors. The encoded protein may play a role in modulating neurite activity. It is involved in synaptogenesis and promotes excitatory synapse differentiation (Beaubien et al., 2016; Kang et al., 2016).

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
SLITRK2 variants associated with neurodevelopmental disorders impair excitatory synaptic function and cognition in mice
DD, ID
ASD, ADHD, epilepsy/seizures
Support
Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
Support
Identification of MAGUK scaffold proteins as intracellular binding partners of synaptic adhesion protein Slitrk2
Support
Slitrk2 controls excitatory synapse development via PDZ-mediated protein interactions
Support
Slitrk Missense Mutations Associated with Neuropsychiatric Disorders Distinctively Impair Slitrk Trafficking and Synapse Formation
Support
Slitrk1 is localized to excitatory synapses and promotes their development
Support
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.
SCZ
Support
Loss-of-function variant in the LRR domain of SLITRK2 implicated in a neurodevelopmental disorder
ASD, ADHD, DD, ID

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN1339R001 
 stop_gained 
 c.1381G>T 
 p.Glu461Ter 
 De novo (germline mosaicism) 
  
 Multiplex 
 GEN1339R002 
 missense_variant 
 c.934A>G 
 p.Thr312Ala 
 Familial 
 Maternal 
 Simplex 
 GEN1339R003 
 missense_variant 
 c.1276C>T 
 p.Arg426Cys 
 De novo 
  
 Simplex 
 GEN1339R004 
 missense_variant 
 c.1531G>A 
 p.Val511Met 
 Familial 
 Maternal 
 Simplex 
 GEN1339R005 
 missense_variant 
 c.221T>C 
 p.Leu74Ser 
 Familial 
 Maternal 
 Simplex 
 GEN1339R006 
 missense_variant 
 c.1121C>G 
 p.Pro374Arg 
 Familial 
 Maternal 
 Simplex 
 GEN1339R007 
 missense_variant 
 c.628G>A 
 p.Glu210Lys 
 Familial 
 Maternal 
 Simplex 
 GEN1339R008 
 missense_variant 
 c.2374C>T 
 p.Arg792Cys 
 Familial 
 Maternal 
 Simplex 
 GEN1339R009 
 missense_variant 
 c.931C>G 
 p.Pro311Ala 
 Unknown 
  
 Simplex 
 GEN1339R010 
 missense_variant 
 c.1451G>A 
 p.Arg484Gln 
 Familial 
 Maternal 
 Simplex 
 GEN1339R011 
 missense_variant 
 c.601G>A 
 p.Val201Ile 
 Familial 
 Maternal 
 Simplex 
 GEN1339R012 
 missense_variant 
 c.1665G>C 
 p.Glu555Asp 
 Unknown 
  
 Simplex 
 GEN1339R013 
 missense_variant 
 c.26G>T 
 p.Ser9Ile 
 Familial 
 Maternal 
  
 GEN1339R014 
 missense_variant 
 c.44G>A 
 p.Gly15Glu 
 Familial 
 Maternal 
  
 GEN1339R015 
 missense_variant 
 c.265G>A 
 p.Val89Met 
 Familial 
 Maternal 
 Multiplex 
 GEN1339R016 
 stop_gained 
 c.789T>A 
 p.Cys263Ter 
 Familial 
 Maternal 
 Simplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
X
Deletion
 1
 
X
Duplication
 1
 
X
Deletion-Duplication
 22
 
X
Deletion
 2
 
X
Deletion
 1
 
X
Deletion
 2
 
X
Deletion-Duplication
 1
 
X
Deletion
 2
 
X
Deletion-Duplication
 1
 
X
Deletion
 1
 
X
Deletion-Duplication
 13
 
X
Deletion
 12
 

M_SLITRK2_3_CKO_HM_CA1_AAV-SLITRK2

Rescue Type: RESCUE-Genetic
Rescue Paradigm: Adeno-associated viruses (AAVs) expressing Cre and wildtype Slitrk2 were stereotactically injected into the CA1 region of adult Slitrk2-floxed mice.

M_SLITRK2_3_CKO_HM_CA1_AAV-SLITRK2

Category
Entity
Effect on phenotype Qualification
Restored Treatment improves measured phenotype significantly
Refractory Treatment does not improve measured phenotype (was expected to do so)
Ameliorated Treatment provides partial correction or improvement of measured phenotype
No adverse effect Treatment does not affect the parameter adversely
Sustained effect Treatment has long term effect of restoration or amelioration, tested AFTER stopping administration (not applied for continuing long-term treatment) . Will be applied only where treatment has had restorative effects during administration or in the first battery of tests conducted.
No sustained effect Treatment has no long term of restoration or amelioration detectable, after stopping administration. Will be applied only where treatment has had restorative effects during administration or in the first battery of tests conducted.
Unexpected results Treats an unexpected phenotype
Side effect Exaggerates an unexpected phenotype
Experimental Paradigm
Age at Testing
Synapse density1
Restored
Description: Co-expression of SLITRK2 WT, but not that of the SLITRK2 T312A variant, completely rescued the decreased integrated intensity of VGLUT1 and PSD-95 puncta in hippocampal CA1-specific Slitrk2-cKO mice.
Exp Paradigm: VGLUT1, PSD-95
 Immunohistochemistry
 unreported
 Not Reported:

M_SLITRK2_3_CKO_HM_CA1

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
 Synapse density1
 Decreased
Description: Hippocampal CA1-specific Slitrk2 cKO mice exhibited a significant reduction in the integrated intensity of VGLUT1 and PSD-95 puncta in the SO and SR layers.
Exp Paradigm: VGLUT1, PSD-95
 Immunohistochemistry
 unreported
 Neuroreceptor levels: TrkB1
 Abnormal
Description: SLITRK2 deletion in hippocampal CA1 lysates induced a significant increase in TrkB-FL (full-length receptors) and decrease in TrkB-T (truncated TrkB isoforms) compared to delta Cre AAV mice.
Exp Paradigm: TrkB-FL, TrkB-T
 Western blot
 unreported
 Miniature post synaptic current frequency: excitatory1
 Decreased
Description: Hippocampal CA1-specific Slitrk2 cKO mice displayed decreased the frequency of mEPSCs compared to wildtype control mice.
 Whole-cell voltage clamp
 unreported
 Spatial reference memory: long term recall1
 Decreased
Description: CA1 region-specific Slitrk2-cKO mice exhibited impaired retention of spatial reference memory after 17 days compared to normal Slitrk2-cKO mice.
 Barnes maze test
 unreported
 Spatial reference memory1
 Decreased
Description: CA1 region-specific Slitrk2-cKO mice exhibited impaired retention of spatial reference memory after 3 days compared to normal Slitrk2-cKO mice.
 Barnes maze test
 unreported
Spatial learning1
 No change
 Barnes maze test
 unreported
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell voltage clamp
 unreported
 Not Reported:

No PIN Data Available
HELP
Copyright © 2017 MindSpec, Inc.